Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 110486
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110486
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110486
Figure 1 Proposed diagnostic and management algorithm for peritoneal metastases in patients with inflammatory bowel disease.
IBD: Inflammatory bowel disease; PM: Peritoneal metastases; CRS/HIPEC: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy; PSC: Primary sclerosing cholangitis; MRI: Magnetic resonance imaging; CEA: Carcinoembryonic antigen; PET: Positron emission tomography; MSI: Microsatellite instability; PCI: Peritoneal cancer index; ERAS: Enhanced recovery after surgery.
- Citation: Paramythiotis D, Tsavdaris D, Geropoulos G, Sacchet DA, Psarras K. Management of peritoneal metastases from colorectal cancer and small bowel adenocarcinoma in patients with inflammatory bowel disease. World J Gastrointest Oncol 2025; 17(11): 110486
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/110486.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.110486
